![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LC Iorio, A Barnett, FH Leitz, VP Houser and CA Korduba
SCH 23390 [R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3- benzazepine-7-ol) possesses pharmacologic effects similar to standard antipsychotics, including selective supression of conditioned avoidance responding in rats and squirrel monkeys, blockade of apomorphine- induced stereotypy in rats and blockade of methamphetamine-induced lethality in aggregated mice. At effective doses in these tests, no changes in gross behavior, neurological or autonomic function were observed. In contrast to the standards tested, SCH 23390 blocked dopamine-stimulated adenylate cyclase at concentrations (IC50 = 0.01 microM) about 2000 times lower than those needed to block spiperone binding (IC50 = 24 microM). This suggests specific D1-receptor antagonism. Inability of SCH 23390 to cause hyperprolactinemia, considered to be a D2-receptor effect, is consistent with this hypothesis. SCH 23390 showed lower increases in dopamine turnover suggesting that the blockade of SCH 23390 may be more specific for post- than presynaptic sites. Additional evidence for the selectivity of SCH 23390 among putative postsynaptic dopamine sites includes its lack of effect on apomorphine-induced hypothermia or emesis. Based on these results, it is postulated that SCH 23390 is a selective D1-receptor antagonist.
This article has been cited by other articles:
|
|
 |
|
  G. Genovese, M. Senek, N. Ortiz, M. Regueira, D. W. Towle, M. Tresguerres, and C. M. Luquet Dopaminergic regulation of ion transport in gills of the euryhaline semiterrestrial crab Chasmagnathus granulatus: interaction between D1- and D2-like receptors J. Exp. Biol., July 15, 2006; 209(14): 2785 - 2793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Meloni, L. P. Gerety, A. T. Knoll, B. M. Cohen, and W. A. Carlezon Jr Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J. Neurosci., April 5, 2006; 26(14): 3855 - 3863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Y. Choi, P. D. Balsam, and J. C. Horvitz Extended Habit Training Reduces Dopamine Mediation of Appetitive Response Expression J. Neurosci., July 20, 2005; 25(29): 6729 - 6733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shankar, S. Murugappan, S. Kim, J. Jin, Z. Ding, K. Wickman, and S. P. Kunapuli Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses Blood, September 1, 2004; 104(5): 1335 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Eyny and J. C. Horvitz Opposing Roles of D1 and D2 Receptors in Appetitive Conditioning J. Neurosci., March 1, 2003; 23(5): 1584 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Capper-Loup, J. J. Canales, N. Kadaba, and A. M. Graybiel Concurrent Activation of Dopamine D1 and D2 Receptors Is Required to Evoke Neural and Behavioral Phenotypes of Cocaine Sensitization J. Neurosci., July 15, 2002; 22(14): 6218 - 6227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. Kuzhikandathil and G. S. Oxford Classic D1 Dopamine Receptor Antagonist R-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) Directly Inhibits G Protein-Coupled Inwardly Rectifying Potassium Channels Mol. Pharmacol., July 1, 2002; 62(1): 119 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Karlsson, L. Farde, C. Halldin, and G. Sedvall PET Study of D1 Dopamine Receptor Binding in Neuroleptic-Naive Patients With Schizophrenia Am J Psychiatry, May 1, 2002; 159(5): 761 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Waszczak, L. P. Martin, H. E. Finlay, N. Zahr, and J. R. Stellar Effects of Individual and Concurrent Stimulation of Striatal D1 and D2 Dopamine Receptors on Electrophysiological and Behavioral Output from Rat Basal Ganglia J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 850 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ranaldi and R. A. Wise Blockade of D1 Dopamine Receptors in the Ventral Tegmental Area Decreases Cocaine Reward: Possible Role for Dendritically Released Dopamine J. Neurosci., August 1, 2001; 21(15): 5841 - 5846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Ruskin, D. A. Bergstrom, and J. R. Walters Multisecond Oscillations in Firing Rate in the Globus Pallidus: Synergistic Modulation by D1 and D2 Dopamine Receptors J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1493 - 1501. [Abstract] [Full Text]
|
|
|
|
|
|
D. N. Ruskin, S. S. Rawji, and J. R. Walters Effects of Full D1 Dopamine Receptor Agonists on Firing Rates in the Globus Pallidus and Substantia Nigra Pars Compacta In Vivo: Tests for D1 Receptor Selectivity and Comparisons to the Partial Agonist SKF 38393 J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 272 - 281. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Lewis, V. J. Watts, C. P. Lawler, D. E. Nichols, and R. B. Mailman Homologous Desensitization of the D1A Dopamine Receptor: Efficacy in Causing Desensitization Dissociates from Both Receptor Occupancy and Functional Potency J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 345 - 353. [Abstract] [Full Text]
|
|
|
|
|
|
E. Acquas, C. Wilson, and H. C. Fibiger Nonstriatal Dopamine D1 Receptors Regulate Striatal Acetylcholine Release In Vivo J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 360 - 368. [Abstract] [Full Text]
|
|
|
|
|
|
T. Momiyama and J. A. Sim Modulation of Inhibitory Transmission by Dopamine in Rat Basal Forebrain Nuclei: Activation of Presynaptic D1-like Dopaminergic Receptors J. Neurosci., December 1, 1996; 16(23): 7505 - 7512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sharifzadeh, A.R. Dehpour, M. Samini, H. Hassan-Mazandarani, T. Samadian, and Gh. R. Asghari Alterations of bromocriptine-induced penile erection by chronic lithium in rats J Psychopharmacol, January 1, 1996; 10(2): 157 - 161. [Abstract] [PDF]
|
|
|
|
|
|
E. Ongini and M. Trampus Modulation of sleep and waking states by D-1 receptors J Psychopharmacol, January 1, 1992; 6(1): 61 - 67. [Abstract] [PDF]
|
|
|
|
|
|
J. L. Waddington Functional interactions between D-1 and D-2 dopamine receptor systems: their role in the regulation of psychomotor behaviour, putative mechanisms, and clinical relevance J Psychopharmacol, January 1, 1989; 3(2): 54 - 63. [PDF]
|
|
|
|
 |
|
 Walters JR, D. Bergstrom, J. Carlson, T. Chase, and A. Braun D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects Science, May 8, 1987; 236(4802): 719 - 722. [Abstract] [PDF]
|
|
|
|
|
|
S. D. Iversen Is it possible to model psychotic states in animals? J Psychopharmacol, January 1, 1987; 1(3): 154 - 176. [PDF]
|
|
|
|
|
|
A. G. Molloy and J. L. Waddington Pharmacological characterization in the rat of grooming and other behavioural responses to the D1 dopamine receptor agonist R-SK&F 38393 J Psychopharmacol, January 1, 1987; 1(3): 177 - 183. [Abstract] [PDF]
|
|
|
|
|
|
C. Reavill and I.P. Stolerman Interaction of nicotine with dopaminergic mechanisms assessed through drug discrimination and rotational behaviour in rats J Psychopharmacol, January 1, 1987; 1(4): 264 - 273. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
